Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 11/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.54 |
| ▸ | MAPT | P10636 | 8/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.54 |
| ▸ | HPGD | P15428 | 8/20 | 0.54 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 6/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17725644 | 1.00 | MEN1 (0.54) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL21728279 | 0.98 | MEN1 (0.53) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL17725650 | 0.98 | MEN1 (0.53) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL19483233 | 0.98 | MEN1 (0.57) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL19483245 | 0.98 | MEN1 (0.53) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL17725013 | 0.98 | MEN1 (0.53) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL19313830 | 0.98 | MEN1 (0.53) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL17725020 | 0.93 | MEN1 (0.49) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL17725651 | 0.93 | MEN1 (0.49) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL17725006 | 0.91 | CYP1A1 (0.54) | MEN1KMT2AMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3389108-B1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEMICAL LTD (KR) | 2023-09-13 | — | — | EP | disclosed |
| US-11723268-B2 | Organic light-emitting element | LG CHEM, LTD. | 2023-08-08 | — | — | US | disclosed |
| US-11723268-B2 | Organic light-emitting element | LG CHEM, LTD. | 2023-08-08 | — | — | US | disclosed |
| EP-3388496-B1 | ORGANIC LIGHT-EMITTING ELEMENT COMPRISING DIBENZOFURAN-ANTHRACENE DERIVATIVE IN LIGHT EMITTING LAYER AND DIPHENYLMETHYL DERIVATIVE IN ELECTRON INJECTION LAYER | LG CHEMICAL LTD (KR) | 2021-02-24 | — | — | EP | disclosed |
| US-20200136053-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2020-04-30 | — | — | US | disclosed |
| EP-3214084-B1 | CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2020-02-19 | — | — | EP | disclosed |
| US-10431748-B2 | Cyclic compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2019-10-01 | — | — | US | disclosed |
| US-20190019961-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2019-01-17 | — | — | US | disclosed |
| US-20170301866-A1 | CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2017-10-19 | — | — | US | disclosed |
| US-20170301866-A1 | CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2017-10-19 | — | — | US | disclosed |
| EP-3214084-A2 | CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG Chem, Ltd. (KR) | 2017-09-06 | — | — | EP | disclosed |
| WO-2016068478-A2 | CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2016-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170301866-A1 | CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | MEN1 599/4885KMT2A 1068/4885MAPT 965/4885 |
| US-11723268-B2 | Organic light-emitting element | CRY2, NR2E3, CRY1 | MEN1 1662/4885KMT2A 931/4885MAPT 554/4885 |
| US-10431748-B2 | Cyclic compound and organic light-emitting element comprising same | CRY1, CRY2, PER2 | MEN1 599/4885KMT2A 1068/4885MAPT 965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.